Related references
Note: Only part of the references are listed.Patient Reported Outcomes Measurement Information System and Quality of Life in Neurological Disorders Measurement System to Evaluate Quality of Life for Children and Adolescents with Neurofibromatosis Type 1 Associated Plexiform Neurofibroma
Jin-Shei Lai et al.
JOURNAL OF PEDIATRICS (2019)
Prevalence of neurofibromatosis type 1 in the Finnish population
Roope A. Kallionpaa et al.
GENETICS IN MEDICINE (2018)
NFM-07. SPRINT: PHASE II STUDY OF THE MEK 1/2 INHIBITOR SELUMETINIB (AZD6244, ARRY-142886) IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1 (NF1) AND INOPERABLE PLEXIFORM NEUROFIBROMAS (PN)
Andrea Gross et al.
NEURO-ONCOLOGY (2018)
Association of plexiform neurofibroma volume changes and development of clinical morbidities in neurofibromatosis 1
Andrea M. Gross et al.
NEURO-ONCOLOGY (2018)
Pain Interference in Youth with Neurofibromatosis Type 1 and Plexiform Neurofibromas and Relation to Disease Severity, Social-Emotional Functioning, and Quality of Life
Pamela L. Wolters et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2015)
Puberty and Plexiform Neurofibroma Tumor Growth in Patients with Neurofibromatosis Type I
Urania Dagalakis et al.
JOURNAL OF PEDIATRICS (2014)
Neurofibromatosis type 1: a multidisciplinary approach to care
Angela C. Hirbe et al.
LANCET NEUROLOGY (2014)
Pediatric Plexiform Neurofibromas: Impact on Morbidity and Mortality in Neurofibromatosis Type 1
Carlos E. Prada et al.
JOURNAL OF PEDIATRICS (2012)
Resection of Plexiform Neurofibromas in Children With Neurofibromatosis Type 1
Federico Canavese et al.
JOURNAL OF PEDIATRIC ORTHOPAEDICS (2011)
Mortality Associated with Neurofibromatosis 1: A Cohort Study of 1895 Patients in 1980-2006 in France
Tu Anh Duong et al.
ORPHANET JOURNAL OF RARE DISEASES (2011)
The Levels of Evidence and Their Role in Evidence-Based Medicine
Patricia B. Burns et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2011)
Birth Incidence and Prevalence of Tumor-Prone Syndromes: Estimates From a UK Family Genetic Register Service
D. G. Evans et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2010)
Neurofibromatosis type 1
Kevin P. Boyd et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas
A. Kim et al.
NEUROLOGY (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
Alessandro Liberati et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
NF1 plexiform neurofibroma growth rate by volumetric MRI - Relationship to age and body weight
E. Dombi et al.
NEUROLOGY (2007)
Retrospective analysis of patients attending a neurofibromatosis type 1 clinic
Fiona Noble et al.
JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2007)
Prevalence of neurofibromatosis 1 in German children at elementary school enrollment
M Lammert et al.
ARCHIVES OF DERMATOLOGY (2005)
Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: A cohort study of 703 patients 2
K Khosrotehrani et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2005)
MR imaging of spinal tumors in children with neurofibromatosis
PL Khong et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2003)
Malignant peripheral nerve sheath tumours in neurofibromatosis 1
DGR Evans et al.
JOURNAL OF MEDICAL GENETICS (2002)
The role of surgery in children with neurofibromatosis
HL Neville et al.
JOURNAL OF PEDIATRIC SURGERY (2001)
Share Paper
